Armstrong Albuterol Sulfate Inhalation Aerosol + Albuterol Sulfate Inhalation Aerosol

Phase 3Terminated
0 watching 0 views this week๐Ÿ“ˆ Rising
72
Hype Score

Development Stage

โœ“
Pre-clinical
โœ“
Phase 1
โœ“
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Asthma

Conditions

Asthma

Trial Timeline

Mar 1, 2008 โ†’ Dec 1, 2008

About Armstrong Albuterol Sulfate Inhalation Aerosol + Albuterol Sulfate Inhalation Aerosol

Armstrong Albuterol Sulfate Inhalation Aerosol + Albuterol Sulfate Inhalation Aerosol is a phase 3 stage product being developed by Amphastar Pharmaceuticals for Asthma. The current trial status is terminated. This product is registered under clinical trial identifier NCT00634517. Target conditions include Asthma.

Hype Score Breakdown

Clinical
27
Activity
18
Company
5
Novelty
9
Community
10

Clinical Trials (1)

NCT IDPhaseStatus
NCT00634517Phase 3Terminated